From: Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase
Angiotensin IV and analogues | ||
---|---|---|
Reference | Ki (nM) * | |
Val-Tyr-Ile-His-Pro-Phe | [21] | 113 |
Nle-Tyr-Ile-His-Pro-Phe | [21] | 340 |
Val-Tyr-Ile-Cys-Pro-Cys | [49] | 25.8† |
Val-Tyr-Ile-[AMPAA] | [49] | 43.6† |
Valψ(CH2NH2)-Tyr-Valψ(CH2NH2)-His-Pro-Phe (divalinal-AT4) | [21] | 2300 |
β2hVal-Tyr-Ile-His-Pro-Phe | [51] | 26‡ |
LVV-hemorphin 7 and analogues | ||
Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe | [48] | 196 |
Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe | [21] | 845 |
Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe | [48] | 56 |
Leu-Val-Val-Tyr-Pro-Trp-Thr | [48] | 560 |
Val-Tyr-Pro-Trp-Thr | [48] | 112 |
Val-Tyr-Pro | [48] | 620 |